![](https://investorshub.advfn.com/uicon/163773.png?cb=1499421946)
Saturday, March 22, 2014 1:24:04 PM
Updates are scheduled for late summer, early fall. Results will be issued in 2015. These updates will not be results but will fuel investor reaction, hence it is not just a throw out of a price, but a legit estimate. Others have said $2.50 but I feel investors are not going to risk in MSTX after how they have treated past investors. That's why I say $1.50 at high. If you look at past share prices, four years ago this was at $4.00.
On a positive note there are no bio companies out there with 40 million in bank for testing, no debt and 2 products in pipeline for testing. That's is plenty for at least 2 years of testing and salary of management. Also MSTX I believe is a prim candidate to be bought up by another larger bio company. Either way do not go on my instruction do your on research. As I stated, I will research, grab a couple stocks then on drops keep adding. Sold my ALU couple months back. Bought at .95 cents sold at about $4.00. Uncle Sams waits until early April for me to do my taxes every year. Keep it till penalty time. Good luck either way.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM